Results for tag: "CXCR4 Inhibitor"

The CXCR4 Inhibitor market is a subset of the Immune Disorders Drugs market. CXCR4 Inhibitors are a type of drug used to treat immune disorders, such as cancer, HIV, and autoimmune diseases. These drugs work by blocking the CXCR4 receptor, which is involved in the regulation of the immune system. CXCR4 Inhibitors are used to reduce inflammation and improve the body's ability to fight off infection. CXCR4 Inhibitors are typically administered orally or intravenously. They are often used in combination with other drugs to maximize their effectiveness. Common side effects of CXCR4 Inhibitors include nausea, vomiting, and diarrhea. Several companies are involved in the CXCR4 Inhibitor market, including AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more